HCV-positive heart and lung transplant likely safe with post-transplant sofosbuvir-velatasivir treatment
1. HCV-naive patients in need of heart or lung transplants who received organs from HCV-positive donors and were treated with ...
Tag: Sofosbuvir-velpatasvir
Sofosbuvir-velpatasvir shows promise in HCV genotype 2 and 3 infection: The ASTRAL 2-3 study
1. Among patients with hepatitis C virus (HCV) genotype 2 or 3, 12 weeks of treatment with a once-daily, fixed-dose, ...